Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.
Press releases published on July 7, 2025
ViewFest2025 The Largest Mental Health Festival in the USA Returns July 13 - Celebrate Mental Health, Community & Hope
Together we walk to celebrate our journey, create community, and inspire hope. WALLED LAKE, MI, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- ViewFest2025, the nation’s largest mental health and prevention festival of its kind, returns to the …
The Talk Awards Honors Three Businesses with 14th Straight Award for Customer Service and Satisfaction
Three businesses add to their legacy of award-winning customer service. LAPEER, MI, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- Recently, three companies were awarded by the Talk Awards for reaching the highest levels of customer satisfaction …
City Beat News Recognizes Businesses for More than a Decade of Outstanding Customer Satisfaction
Three businesses have earned 11 straight Spectrum Awards for providing stellar customer service. LAPEER, MI, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- A dentist, a staffing agency and a laser hair removal center couldn’t be more different in …
Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance
ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in …
Luma Nutrition Magnesium Glycinate Surpasses 10,000 Monthly Sales on Amazon
Los Angeles, CA , July 07, 2025 (GLOBE NEWSWIRE) -- Luma Nutrition is proud to announce that its flagship product, Luma Nutrition Magnesium Glycinate 1000mg, has officially surpassed 10,000 units sold per month on Amazon. As one of the best magnesium …
Aerolib Healthcare Solutions Unveils Aerolib AI: The Ultimate Appeals Machine
Frisco, TX , July 07, 2025 (GLOBE NEWSWIRE) -- Aerolib Healthcare Solutions, a leader in integrating clinical expertise with technology and regulatory strategy, proudly announces the launch of Aerolib AI: The Ultimate Appeals Machine. This innovative …
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
SUNNYVALE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a leading medical technology company transforming the diagnosis and management of patients with serious neurological conditions, announced today that it filed …
FibroBiologics’ to Present at Exclusive Live Investor Webinar and Q&A Session on July 10
HOUSTON, July 07, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic …
SafeSpace Global Corporation welcomes Katie Piperata as its Vice President of Senior Living
Senior Living Leader Brings Full-Spectrum Industry Experience to Guide AI Transformation Across the Sector Knoxville, TN, July 07, 2025 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID:SSGC), a global leader in multimodal AI technology, is pleased …
NANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3)
Health authorities in major European countries have accepted the reclassification of JNJ-1900 (NBTXR3) from a medical device to a medicinal product, aligning with regulatory status in the US and other major markets Medicinal product classification supports …
NANOBIOTIX annonce une harmonisation réglementaire et le dépôt d’une demande d’un nouveau brevet de composition de matière pour JNJ-1900 (NBTXR3)
Les autorités de santé des principaux pays européens ont accepté la reclassification de JNJ-1900 (NBTXR3) en tant que médicament, au lieu de dispositif médical, alignant ainsi son statut réglementaire sur celui en vigueur aux États-Unis et dans d'autres …
Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders
Potential Distribution Range of $0.04 to $0.08 per share of outstanding stock based on current estimates and assumptions, including timely approval of Distribution Proposal Failure to approve Dissolution Proposal will reduce or eliminate any potential …
Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that, on July 1, 2025, the company …
Merit Medical Names Martha Aronson as New President and Chief Executive Officer
Fred Lampropoulos will continue to serve as Chairman of Merit’s Board of Directors Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025 SOUTH JORDAN, Utah, July 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: …
Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders
Meeting adjourned to Monday, July 21, 2025 at 9:30 a.m. Mountain Time BROOMFIELD, Colo., July 07, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that leverages Magnetic Resonance …
Ascendis to Share Its Latest Endocrinology Rare Disease Data at ENDO 2025
COPENHAGEN, Denmark, July 07, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced two oral presentations at ENDO 2025, the annual meeting of the Endocrine Society being held July 12-15, 2025, in San Francisco. Dr. Aliya Khan will …
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on July 1, 2025, it awarded …
Inventiva receives $10 million milestone payment from CTTQ
Daix (France), New York City (New York, United States), July 7, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of …
Inventiva receives $10 million milestone payment from CTTQ
Daix (France), New York City (New York, United States), July 7, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of …
DNA and RNA Sequencing Markets Set for Rapid Expansion, Says BCC Research
Boston, July 07, 2025 (GLOBE NEWSWIRE) -- BCC Research announces the release of its 2024 DNA and RNA Synthesis Research Review, offering detailed insights into the markets shaping genetic research and biotechnology. This review highlights the market growth …